No. Regulatory submission translation, multilingual regulatory dossier translation, EMA submission localization and medical regulatory translation do not guarantee regulatory approval, EMA acceptance, authority acceptance, notified body acceptance, dossier validation, certification, compliance, legal validity, product approval, CE marking, market access or business outcomes. These outcomes depend on the client's regulatory strategy, dossier content, clinical, medical, legal, quality, pharmacovigilance and local affiliate teams, and on the relevant authority, notified body or agency. AbroadLink supports translation, review, terminology, workflow selection and traceability across languages, while submission decisions remain the responsibility of the client.